Boltz CEO Gabriele Corso hosts AMA: 3 of top-20 pharma partnered, 100K scientists use its models
GabriCorso · x · 2026-10-13
Gabriele Corso, co-founder and CEO of Boltz (the team behind Boltz-1, Boltz-2 and BoltzGen), is hosting an AMA on BITS in bio through Wednesday.
Key facts:
- Boltz has partnered with 3 of the top 20 pharma companies: Pfizer, Takeda and GSK
- Over 100,000 scientists have used Boltz's protein engineering models in just two years
- The AMA runs on Slack, inviting questions on the future of protein engineering
More from Companies & People
- AI Engineer New York opens with a print daily: 300K-dev telemetry says org, not model — jonmarkgo · 2026-10-13
- Palantir CEO Karp: super-high aptitude won't fit a pre-shaped slot — eliano · 2026-10-13
- a16z's Gavin Baker: Meta is back in the AI race while Gemini has fallen out of the conversation — a16z · 2026-10-13
- UT San Antonio launches 15-credit Applied AI in Language Education graduate certificate — lmoroney · 2026-10-13
- Google's enterprise Gemini agent: one memory across Workspace, M365 and Slack, routes work to Claude — BenBajarin · 2026-10-13
- Meta skipped the 'too dangerous to release' marketing for Muse Wonder — and could rival Google — haider1 · 2026-10-13